This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home    About    Scholarships    Meetings    Publications    Resources    Join ASCLS Aug. 9, 2011
ASCLS eNewsBytes
Aug. 9, 2011
ASCLS Quick Links >   Home    About    Scholarships    Meetings    Publications    Resources


Bypassing stem cells, scientist make neurons directly from human skin
ScienceDaily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers have come up with a recipe for making functional neurons directly from human skin cells, including those taken from patients with Alzheimer's disease. The new method may offer a critical short cut for generating neurons for replacement therapies of the future. Already, the converted neurons are beginning to yield insights into what goes wrong in the Alzheimer's brain and how diseased neurons might respond to treatment. More



Report: Exercise benefits cancer survivors
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
If exercise were a cancer drug, it would be a blockbuster, appears to be the conclusion of a new review on the benefits of physical activity to people surviving and living beyond cancer. In a report released, the leading charity Macmillan Cancer Support firmly sweeps aside the tradition that cancer patients should "rest up" and "take it easy." It urges doctors and nurses to prescribe physical activity to patients "at all stages of cancer from initial diagnosis through to the later stages." However, despite the emergence of this evidence, many health professionals are failing to tell their cancer patients about the benefits of exercise. More

Study: Counseling may help women at risk for breast cancer gene
HealthDay News via USA Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Although women whose mothers had breast cancer may worry about developing cancer themselves, many do not fully understand when and why they should be screened or their options to reduce their risk for the disease, a new study suggests. "Young, high-risk women have little knowledge about the probabilities and options for managing the cancers for which their risks are remarkably increased. Further, many report intense anxiety related to their potential cancer development," principal investigator Andrea Farkas Patenaude said in an institute news release. More

STA Coag ConneXion

STA Coag ConneXion is an easy to use, Windows 7 based user interface that offers comprehensive QC management, remote QC capability and standardized result reporting with the use of expert rules for auto validation. For more information on STA Coag ConnneXion, visit www.stago-us.com.


Compare hospitals on heart attack, heart failure and pneumonia
USA Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Check out interactive USA Today graphic where you'll find death and readmission rates for heart attack, heart failure and pneumonia for more than 4,000 hospitals. The data are compiled by the Centers for Medicare and Medicaid Services and cover a three-year period from mid-2007 to 2010. The agency also supplied the information to the hospitals and posted the data on its Hospital Compare website. More

Staffing crucial to HIV testing in the emergency department
Internal Medicine News Digital Network    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Of the more than 1 million HIV-positive patients in the United States, approximately 21 percent are undiagnosed, as more than 50,000 new infections occur annually. The emergency department is recognized as an important point of access to HIV testing for many patients. More

A breath of fresh air in diagnostics

Providing the accurate, dependable allergy, urinalysis and auto-immune results you require. Delivering the cost-effective test results you value.
MORE


Inappropriate use of blood cell booster widespread
Reuters Health    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Costly drugs that boost red blood cells are being routinely misused in cancer patients, raising concerns about side effects and wasted resources, researchers say. A quarter of the time, they found patients got the so-called erythropoiesis-stimulating agents for no more than a week, which is too short to do much good. More

At Phadia®, we see things differently.

See what we see. For cutting-edge testing technologies for allergic and autoimmune diseases… Look no further than Phadia. Contact us today at 800.346.4364 or www.phadia.us.


US Food and Drug Administration approves molecular test for hepatitis C
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Abbott announced that it has received approval from the U.S. Food and Drug Administration to market its RealTime polymerase chain reaction test for measuring the viral load of hepatitis C, the leading cause of liver cancer in the United States. The Abbott RealTime HCV assay is intended for use as an aid in the management of HCV-infected patients undergoing antiviral therapy. More

A new suspect in the obesity epidemic: Our brains
Discover Magazine    Share    Share on FacebookTwitterShare on LinkedinE-mail article
According to a study, nine states had an obesity rate of at least 30 percent — compared with zero states some 10 years earlier. "I call it the hungry brain syndrome," says Hans-Rudolf Berthoud, an expert in the neurobiology of nutrition. More

Groundbreaking EIA Tumor Marker Kits

Fujirebio Diagnostics, Inc. invites you to learn more about our HE4 (ovarian) and CYFRA 21-1™ (lung) tumor marker EIA kits used for disease management. MORE


Study: Urine test for prostate cancer may be better than blood test
Los Angeles Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Prostate cancer screening may become significantly better with the use of a urine test, according to a new study. Prostate cancer screening is currently based on a blood test to detect PSA — prostate-specific antigen. But that test often produces false positives and leads to unnecessary biopsies. More
Triturus - True Open Flexibility
As a leader in fully automated immunoassay testing systems, Grifols USA Diagnostic Division’s premier product, the TRITURUS® ELISA System is an open, fully automated, multi-test and multi-batch immunoassay system. Grifols USA is a major distributor of quality IVD ELISA tests for Infectious Disease, Autoimmune Diseases and many other disease states. Grifols’ Diagnostic products take the complexity out of clinical diagnostic testing.

Contact us at 1-800-379-0957.
CellaVision Automates and Standardizes the Manual Differential

CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes. More
Trust in Cleveland Clinic Laboratories
Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit clevelandcliniclabs.com.
This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here.

Did someone forward this edition to you? Subscribe here - it's free!

Advertise

Colby Horton, Vice President of Publishing
469.420.2601

Download Media Kit

To contribute news to the ASCLS eNewsBytes, contact Yvette Craig, Senior Content Editor
469.420.2641.

Recent Issues

  • Aug. 2, 2011
  • July 26, 2011
  • July 19, 2011
  • July 12, 2011
  • July 5, 2011
  •  RSS Feed
    Most popular articles